Clinical Trials Logo

Filter by:
NCT ID: NCT04911127 Completed - Clinical trials for Rheumatoid Arthritis

Therapeutic Response of Cannabidiol in Rheumatoid Arthritis

Start date: October 5, 2021
Phase: Phase 1
Study type: Interventional

The study will randomly assign Rheumatoid Arthritis (RA) patients on stable RA therapy to either placebo or cannabidiol (CBD). The overall goal of this proposal is to examine the efficacy and safety of CBD treatment as adjunctive to the medical management of RA patients.

NCT ID: NCT04911062 Completed - Post-Operative Pain Clinical Trials

HTX-011 in Spinal Surgery

Start date: April 7, 2022
Phase: Phase 2
Study type: Interventional

This is a Phase 2, multicenter study in subjects undergoing an open lumbar decompression surgery.

NCT ID: NCT04910165 Completed - Pain, Postoperative Clinical Trials

Exparel Use in Adductor Canal Block After Total Knee Arthroplasty

Start date: June 1, 2020
Phase: Phase 3
Study type: Interventional

Exparel has been shown to have better pain control compared to previously used infiltration agents, including bupivacaine, while having a minor side effect profile. The purpose of this study is to explore the effectiveness of Exparel (liposomal bupivacaine) in Adductor Canal Blocks for peri-operative pain control following a total knee arthroplasty (TKA) procedure.

NCT ID: NCT04910139 Completed - Nasal Congestion Clinical Trials

A User Study of the Soniflow System for Nasal Congestion Relief

Start date: July 15, 2020
Phase: N/A
Study type: Interventional

The Soniflow System consists of an acoustic vibrational headband paired with a Smartphone App to provide rapid relief of nasal congestion.

NCT ID: NCT04910100 Completed - Ocular Hypertension Clinical Trials

Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension

Start date: April 15, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety (in the eye and throughout the body) and effectiveness of nebivolol (0.5 and 1 percent) and timolol (0.5 percent) eye drop suspensions. These eye drops will be compared to timolol 0.5 percent eye drop solution in participants with open angle glaucoma (the most common type of glaucoma) or high eye pressure (ocular hypertension).

NCT ID: NCT04909853 Completed - Renal Impairment Clinical Trials

Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.

Start date: June 15, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1, non-randomized, open-label, 2-part study to investigate the effect of renal impairment on the pharmacokinetics (PK), safety and tolerability of a single oral dose of PF-07321332 in combination with the PK boosting agent ritonavir. Participants will be selected and categorized into normal renal function or renal impairment groups based on their estimated glomerular filtration rate. Part 1: will be conducted in approximately 24 participants (approximately 8 per group) with stable mild or moderate renal impairment and a control group of participants with normal renal function. Part 2 will be conducted in approximately 8 participants with stable severe renal impairment.

NCT ID: NCT04909359 Completed - Ulcerative Colitis Clinical Trials

Characterization of CD Responders to Vedolizumab

Start date: August 25, 2015
Phase:
Study type: Observational

The purpose of this study is to characterize which patients with Crohn's disease are likely to respond to standard of care to vedolizumab therapy.

NCT ID: NCT04909242 Completed - Healthy Volunteers Clinical Trials

Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants

Start date: April 21, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1, randomised, double-blind, placebo-controlled, single ascending dose sequential group study in healthy participants. This study consists of three parts: Part A (single dose escalation, SAD) , Part B (food effect, FE) and Part C (relative bioavailability, BA).

NCT ID: NCT04909229 Completed - Insomnia Chronic Clinical Trials

Prescription Digital Therapeutic for the Treatment of Insomnia

SLEEP-I
Start date: December 20, 2021
Phase: N/A
Study type: Interventional

This will be a prospective multi-center controlled trial of 100 patients conducted to assess the real-world effectiveness of a mobile-delivered, prescription digital therapeutic (PDT) device delivering Cognitive Behavioral Therapy for Insomnia using a novel patient-centered data-sharing platform with linkage to Fitbit for 61 weeks

NCT ID: NCT04909216 Completed - Trauma Clinical Trials

Mindful Attention Training Workshop for Firefighters

HAZMAT
Start date: May 5, 2021
Phase: N/A
Study type: Interventional

The overarching goal of this study is to demonstrate the efficacy, feasibility, and acceptability of Mindful Attention Training (MAT), a novel mindfulness-based intervention that is specifically developed for firefighters. This project is designed to improve the health of firefighters, an integral, essential component of our national and international communities. Moreover, the study aims to promote health service psychologists by enhancing our contributions to the mental healthcare of firefighters, an understudied and underserved segment of the population by virtue of their service to our communities. This study therefore has significant potential to identify, develop, and promote an effective model of quality, evidence-based mental health promotion and illness prevention by integrating health service psychology into the fire service.